HOME >> MEDICINE >> NEWS
Asthmatx completes enrollment in pivotal study of bronchial thermoplasty

San Francisco, CA, May 21, 2007 Asthmatx, Inc., a medical device company that has developed a catheter-based procedure for the treatment of asthma, announced today the successful completion of enrollment in its pivotal FDA approved IDE study, the Asthma Intervention Research 2 (AIR2) Trial of the Alair Bronchial Thermoplasty System. Bronchial Thermoplasty is a non-drug treatment for asthma under clinical investigation in the United States. The minimally invasive, bronchoscopic procedure uses thermal energy to reduce the airway smooth muscle responsible for constriction in asthma patients.

Leading asthma and bronchoscopy experts are participating in this international, multicenter AIR2 Trial to establish the safety and efficacy of the Alair System. Nearly 300 patients were enrolled in the study during the last 18 months at over 30 world-renowned medical centers including 15 US research hospitals. The AIR2 Trial is the fourth clinical study of the Alair Bronchial Thermoplasty System. To date, over 700 bronchoscopic procedures have been performed on asthma patients.

"We are very pleased to be a participant in this very important AIR2 Trial, the success of which will result in an important advancement in the treatment of severe asthma," states Mario Castro, MD, Associate Professor at the Washington University School of Medicine and Asthma Center, and a Principal Investigator in the AIR2 Trial. "As the lead enrolling center in the United States, we have experienced significant patient interest in bronchial thermoplasty, which we hope may become a new option for patients with difficult-to-treat asthma."

Final results of the first randomized and controlled clinical study of bronchial thermoplasty, the Asthma Intervention Research (AIR) Trial, were also reported today at the annual scientific assembly of the American Thoracic Society (ATS) by Gerard Cox, MB, Professor of Medicine, McMaster University, Canada, and principal investigato
'"/>

Contact: Meghan Oreste
moreste@comcast.net
617-823-1441
Asthmatx
21-May-2007


Page: 1 2

Related medicine news :

1. Acrux completes enrollment in key phase 2 trial
2. MacroChem completes patient enrollment for Phase II trial of EcoNail for treatment of onychomycosis
3. GroPep completes final milestone of the path malaria vaccine initiative
4. Im a Kid Too project completes first phase
5. Approval to start US BTT pivotal trial
6. Bayer and Onyx announce pivotal Nexavar kidney cancer study published in NEJM
7. New data show CAS in clinical practice has comparable MAE rate with pivotal sapphire trial
8. Now is a pivotal point in history to abolish state execution
9. Orqis Medical receives unconditional FDA approval for pivotal trial of percutaneous CHF therapy
10. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
11. Penn study finds pro-death proteins required to regulate healthy immune function

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/10/2020)... CHICAGO (PRWEB) , ... July 09, 2020 , ... Ziegler, ... 2020 Bank Bonds for Michigan Christian Home d/b/a Beacon Hill at Eastgate (Beacon Hill). ... amortization and a $12,700,000 short-term loan with a 3-year amortization that will be retired ...
(Date:7/7/2020)... , ... July 07, 2020 , ... Dr. Louis ... a new way to improve their scalp health. It is now possible to receive ... this treatment process to his practice, Dr. DeJoseph is able to provide clients with ...
(Date:7/4/2020)... ... July 03, 2020 , ... MemoryCare.com , a ... the Best Memory Care Facilities in Charleston, South Carolina. The guide identifies 5 ... , According to the Alzheimer’s Association , 5.6 million people age ...
(Date:7/2/2020)... , ... July 02, 2020 , ... ... businesses, including dental offices for non-emergency work. In conjunction with the American Dental ... for Connecticut dental practices in mid-May. , Due to safety concerns, the ...
(Date:7/1/2020)... ... July 01, 2020 , ... G-CON Manufacturing, the leader ... Codiak BioSciences to support its cleanroom build out at its new clinical manufacturing ... drug substance and product manufacturing for its clinical pipeline. , Codiak chose PODs ...
Breaking Medicine News(10 mins):
(Date:6/25/2020)... ... June 25, 2020 , ... R3 Medical Training announced today it is now ... several locations. The first course is August 6-7, 2020 in San Diego and the ... as a Virtual Live Stream option. , The two day agenda for each course ...
(Date:6/25/2020)... ... June 25, 2020 , ... BeCurious Studio ... Developers & DesignRush following the launch a recent project. BeCurious Studio, the rule ... cancer survivors. , Commissioned by MyVictory Inc , the platform delivers ...
(Date:6/25/2020)... ... 25, 2020 , ... The Heritage Downtown Active Senior Living Apartment Homes in ... over 100,000 positive cases of the coronavirus in the United States to date, their ... Heritage Downtown, their family members, as well as the Walnut Creek community. , ...
Breaking Medicine Technology:
Cached News: